Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Tao Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7674-698X; OpenAlex author ID A5101760233. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2018: 1 paper · 2019: 3 papers · 2020: 5 papers · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 15

  1. Honokiol Inhibits Stemness in Pancreatic Cancer via Downregulating c-Met Expression. Last author DOI 10.1002/ptr.70176↗
  2. MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. First author DOI 10.1016/j.canlet.2026.218362↗
  3. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Co-author DOI 10.1016/j.biopha.2022.112713↗
  4. Nodal Enhances Perineural Invasion in Pancreatic Cancer by Promoting Tumor-Nerve Convergence. Co-author DOI 10.1155/2022/9658890↗
  5. The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. Co-author DOI 10.1186/s13046-020-01823-4↗
  6. Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling. Co-author DOI 10.3389/fonc.2021.728583↗
  7. Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. Co-author DOI 10.1016/j.biopha.2020.110126↗
  8. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway. Co-author DOI 10.1111/jcmm.15265↗
  9. Sonic hedgehog signaling pathway promotes pancreatic cancer pain via nerve growth factor. Co-author DOI 10.1136/rapm-2019-100991↗
  10. Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation. First author DOI 10.1177/0963689720929987↗
  11. NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer. Co-author DOI 10.3389/fonc.2020.01038↗
  12. EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway. Co-author DOI 10.1111/jcmm.14167↗
  13. Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway. First author DOI 10.1177/0963689719851772↗
  14. Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis. First author DOI 10.2174/1871520619666190626120359↗
  15. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling. Co-author DOI 10.3892/or.2018.6518↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weikun Qian · 10 shared papers, 2018–2026 · strength 1.46
  2. Ying Xiao · 11 shared papers, 2018–2022 · strength 1.24
  3. Qingyong Ma · 11 shared papers, 2018–2022 · strength 1.20
  4. Zheng Wang · 7 shared papers, 2019–2026 · strength 1.10
  5. Jiguang Ma · 9 shared papers, 2018–2022 · strength 0.97
  6. Yiqun Song · 2 shared papers, 2026 · strength 0.57
  7. Yangyang Yue · 3 shared papers, 2020–2026 · strength 0.48
  8. Wanxing Duan · 5 shared papers, 2018–2021 · strength 0.47
  9. Xuqi Li · 4 shared papers, 2018–2020 · strength 0.38
  10. Simei Zhang · 2 shared papers, 2021–2026 · strength 0.36
  11. Zeen Zhu · 2 shared papers, 2021–2026 · strength 0.36
  12. Wunai Zhang · 2 shared papers, 2021–2026 · strength 0.36
  13. Erxi Wu · 3 shared papers, 2020–2022 · strength 0.36
  14. Zheng Wu · 3 shared papers, 2019–2022 · strength 0.35
  15. Liang Han · 3 shared papers, 2020–2021 · strength 0.34
  16. Jie Li · 3 shared papers, 2020–2021 · strength 0.32
  17. Cancan Zhou · 3 shared papers, 2018–2021 · strength 0.30
  18. Jianjun Lei · 3 shared papers, 2019–2021 · strength 0.30
  19. Qinhong Xu · 3 shared papers, 2019–2020 · strength 0.29
  20. Zheng Wang · 2 shared papers, 2019–2020 · strength 0.27
  21. Liang Han · 2 shared papers, 2019–2020 · strength 0.27
  22. Jie Jiang · 2 shared papers, 2019–2020 · strength 0.27
  23. Liang Cheng · 3 shared papers, 2018–2020 · strength 0.26
  24. Ke Chen · 2 shared papers, 2021–2022 · strength 0.25
  25. Zheng Wang · 2 shared papers, 2020–2021 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.